OBJECTIVE: The objective of the study was to measure the performance of a 5-tier, color-coded graded classification of electronic fetal monitoring (EFM). STUDY DESIGN: We used specialized software to analyze and categorize 7416 hours of EFM from term pregnancies. We measured how often and for how long each of the color-coded levels appeared in 3 groups of babies: (A) 60 babies with neonatal encephalopathy (NE) and umbilical artery base deficit (BD) levels were greater than 12 mmol/L; (I) 280 babies without NE but with BD greater than 12 mmol/L; and (N) 2132 babies with normal gases. RESULTS: The frequency and duration of EFM abnormalities considered more severe in the classification method were highest in group A and lowest in group N. Detecting an equivalent percentage of cases with adverse outcomes required only minutes spent with marked EFM abnormalities compared with much longer periods with lesser abnormalities. CONCLUSION: Both degree and duration of tracing abnormality are related to outcome. We present empirical data quantifying that relationship in a systematic fashion. Copyright 2010 Mosby, Inc. All rights reserved.
OBJECTIVE: The objective of the study was to measure the performance of a 5-tier, color-coded graded classification of electronic fetal monitoring (EFM). STUDY DESIGN: We used specialized software to analyze and categorize 7416 hours of EFM from term pregnancies. We measured how often and for how long each of the color-coded levels appeared in 3 groups of babies: (A) 60 babies with neonatal encephalopathy (NE) and umbilical artery base deficit (BD) levels were greater than 12 mmol/L; (I) 280 babies without NE but with BD greater than 12 mmol/L; and (N) 2132 babies with normal gases. RESULTS: The frequency and duration of EFM abnormalities considered more severe in the classification method were highest in group A and lowest in group N. Detecting an equivalent percentage of cases with adverse outcomes required only minutes spent with marked EFM abnormalities compared with much longer periods with lesser abnormalities. CONCLUSION: Both degree and duration of tracing abnormality are related to outcome. We present empirical data quantifying that relationship in a systematic fashion. Copyright 2010 Mosby, Inc. All rights reserved.
Authors: Antoniya Georgieva; Patrice Abry; Václav Chudáček; Petar M Djurić; Martin G Frasch; René Kok; Christopher A Lear; Sebastiaan N Lemmens; Inês Nunes; Aris T Papageorghiou; Gerald J Quirk; Christopher W G Redman; Barry Schifrin; Jiri Spilka; Austin Ugwumadu; Rik Vullings Journal: Acta Obstet Gynecol Scand Date: 2019-06-18 Impact factor: 3.636
Authors: Alan J Rosenbaum; Rachel M Smith; Erinn M Hade; Ashish Gupta; Alper Yilmaz; Michael Cackovic Journal: J Matern Fetal Neonatal Med Date: 2018-12-12
Authors: Suneet P Chauhan; Steven J Weiner; George R Saade; Michael A Belfort; Uma M Reddy; John M Thorp; Alan T N Tita; Russell S Miller; Mara J Dinsmoor; David S McKenna; Bradley Stetzer; Dwight J Rouse; Ronald S Gibbs; Yasser Y El-Sayed; Yoram Sorokin; Steve N Caritis Journal: Obstet Gynecol Date: 2018-10 Impact factor: 7.661
Authors: Václav Chudáček; Jiří Spilka; Miroslav Burša; Petr Janků; Lukáš Hruban; Michal Huptych; Lenka Lhotská Journal: BMC Pregnancy Childbirth Date: 2014-01-13 Impact factor: 3.007
Authors: Lauren M Bullens; Alexandra D J Hulsenboom; Suzanne Moors; Rohan Joshi; Pieter J van Runnard Heimel; M Beatrijs van der Hout-van der Jagt; Edwin R van den Heuvel; S Guid Oei Journal: Trials Date: 2018-03-23 Impact factor: 2.279
Authors: Maria Ribeiro; João Monteiro-Santos; Luísa Castro; Luís Antunes; Cristina Costa-Santos; Andreia Teixeira; Teresa S Henriques Journal: Front Med (Lausanne) Date: 2021-11-30